New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2014
08:03 EDTSPNCSpectranetics price target raised to $30 from $24 at Stifel
Stifel increased its price target on Spectranetics after the company announced positive results from its EXCITE ISR clinical trial. The firm sees the results as a major milestone for Spectranetics and keeps a Buy rating on the shares.
News For SPNC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 7, 2015
10:04 EDTSPNCJPMorgan medical tech analysts hold an analyst/industry conference call
Analysts discuss the recent weakness and physician survey takeaways on an Analyst/Industry conference call on July 7 at 10 am.
July 2, 2015
08:12 EDTSPNCSpectranetics announces federal court awards AngioScore $20M
Subscribe for More Information
June 29, 2015
08:51 EDTSPNCCanaccord reiterates Buy on Avinger, Spectranetics on reimbursement expectations
Subscribe for More Information
June 24, 2015
16:04 EDTSPNCSpectranetics receives FDA 510(k) clearance for larger diameter AngioSculpt
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use